Washington: Researchers have discovered a mechanism that offers a promising new approach for harnessing the immune system to fight cancer in mice without triggering autoimmune reactions.The work by St. Jude Children`s Research Hospital scientists focused on white blood cells called regulatory T cells- which serve as the immune system`s police force and can interfere with the immune system`s ability to fight cancer.In this study, investigators identified a mechanism that boosts the ability of regulatory T cells to cause problems by blocking an effective anti-tumour immune response. The same process, however, plays no role in maintaining immune balance or preventing the misguided immune attack on healthy tissue that leads to autoimmune problems, researchers reported. Blocking this mechanism led to the elimination or dramatic reduction of melanoma by the immune system in mice, without causing the autoimmune and inflammatory problems often associated with current cancer- treatment efforts that target immune regulators, scientists said.The mechanism is built around two proteins. One, semaphorin-4a (Sema4a), is carried on the surface of various immune cells that can spark inflammation. The other, neuropilin-1 (Nrp1), is carried on the surface of regulatory T cells.
Firing across Pak-India border kills two
Ranchi: Violent clashes between JMM, BJP workers
SC refuses to postpone UPSC prelims
Jaipur: Air India flight makes emergency landing due to technical fault